A citation-based method for searching scientific literature

Andrew Davies. Hematol Oncol 2019
Times Cited: 9







List of co-cited articles
30 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
55


Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Andrew D Zelenetz, Gilles Salles, Kylie D Mason, Carla Casulo, Steven Le Gouill, Laurie H Sehn, Herve Tilly, Guillaume Cartron, Martine E D Chamuleau, Andre Goy,[...]. Blood 2019
82
22

Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
Andy I Chen, Jessica T Leonard, Craig Y Okada, Nathan D Gay, Kari Chansky, Guang Fan, Jennifer B Dunlap, Philipp W Raess, Rita M Braziel, Alex Stentz,[...]. Leuk Lymphoma 2018
15
22

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.
Alex F Herrera, Scott J Rodig, Joo Y Song, Young Kim, Gabriel K Griffin, Dongyun Yang, Liana Nikolaenko, Matthew Mei, Victoria Bedell, Paola Dal Cin,[...]. Biol Blood Marrow Transplant 2018
28
22

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Daniel J Landsburg, Marissa K Falkiewicz, Joseph Maly, Kristie A Blum, Christina Howlett, Tatyana Feldman, Anthony R Mato, Brian T Hill, Shaoying Li, L Jeffrey Medeiros,[...]. J Clin Oncol 2017
95
22

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.
Alex F Herrera, Matthew Mei, Lawrence Low, Haesook T Kim, Gabriel K Griffin, Joo Y Song, Reid W Merryman, Victoria Bedell, Christine Pak, Heather Sun,[...]. J Clin Oncol 2017
113
22

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
Norbert Schmitz, Samira Zeynalova, Maike Nickelsen, Roopesh Kansara, Diego Villa, Laurie H Sehn, Bertram Glass, David W Scott, Randy D Gascoyne, Joseph M Connors,[...]. J Clin Oncol 2016
214
22

Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
Yasuhiro Oki, Mansoor Noorani, Pei Lin, Richard E Davis, Sattva S Neelapu, Long Ma, Mohamed Ahmed, Maria Alma Rodriguez, Fredrick B Hagemeister, Nathan Fowler,[...]. Br J Haematol 2014
248
22

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
Wendy Cuccuini, Josette Briere, Nicolas Mounier, Hans-Ullrich Voelker, Andreas Rosenwald, Christer Sundstrom, Sergio Cogliatti, Edouard Hirchaud, Loic Ysebaert, Dominique Bron,[...]. Blood 2012
124
22

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Nathalie A Johnson, Graham W Slack, Kerry J Savage, Joseph M Connors, Susana Ben-Neriah, Sanja Rogic, David W Scott, King L Tan, Christian Steidl, Laurie H Sehn,[...]. J Clin Oncol 2012
661
22

How I treat double-hit lymphoma.
Jonathan W Friedberg. Blood 2017
82
22

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.
Christina Howlett, Sonya J Snedecor, Daniel J Landsburg, Jakub Svoboda, Elise A Chong, Stephen J Schuster, Sunita Dwivedy Nasta, Tatyana Feldman, Allison Rago, Kristy M Walsh,[...]. Br J Haematol 2015
109
22

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Daisuke Ennishi, Aixiang Jiang, Merrill Boyle, Brett Collinge, Bruno M Grande, Susana Ben-Neriah, Christopher Rushton, Jeffrey Tang, Nicole Thomas, Graham W Slack,[...]. J Clin Oncol 2019
153
22

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Adam M Petrich, Mitul Gandhi, Borko Jovanovic, Jorge J Castillo, Saurabh Rajguru, David T Yang, Khushboo A Shah, Jeremy D Whyman, Frederick Lansigan, Francisco J Hernandez-Ilizaliturri,[...]. Blood 2014
298
22

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
22

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.
Nathalie A Johnson, Kerry J Savage, Olga Ludkovski, Susana Ben-Neriah, Ryan Woods, Christian Steidl, Martin J S Dyer, Reiner Siebert, John Kuruvilla, Richard Klasa,[...]. Blood 2009
429
22

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
22

CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial.
Yasuhiro Oki, Kevin R Kelly, Ian Flinn, Manish R Patel, Robert Gharavi, Anna Ma, Jefferson Parker, Amir Hafeez, David Tuck, Anas Younes. Haematologica 2017
72
22



Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Kieron Dunleavy, Michelle A Fanale, Jeremy S Abramson, Ariela Noy, Paolo Fabrizio Caimi, Stefania Pittaluga, Samir Parekh, Ann Lacasce, John W Hayslip, Deepa Jagadeesh,[...]. Lancet Haematol 2018
100
22


Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Andrés E Quesada, L Jeffrey Medeiros, Parth A Desai, Pei Lin, Jason R Westin, Huda M Hawsawi, Peng Wei, Guilin Tang, Adam C Seegmiller, Nishitha M Reddy,[...]. Mod Pathol 2017
35
22


Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Daniel J Landsburg, Adam M Petrich, Jeremy S Abramson, Aliyah R Sohani, Oliver Press, Ryan Cassaday, Julio C Chavez, Kevin Song, Andrew D Zelenetz, Mitul Gandhi,[...]. Cancer 2016
43
22

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.
Sharon Barrans, Simon Crouch, Alex Smith, Kathryn Turner, Roger Owen, Russell Patmore, Eve Roman, Andrew Jack. J Clin Oncol 2010
418
22

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Kerry J Savage, Graham W Slack, Anja Mottok, Laurie H Sehn, Diego Villa, Roopesh Kansara, Robert Kridel, Christian Steidl, Daisuke Ennishi, King L Tan,[...]. Blood 2016
113
22

The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit.
Alexandra Clipson, Sharon Barrans, Naiyan Zeng, Simon Crouch, Nicholas F Grigoropoulos, Hongxiang Liu, Sylvia Kocialkowski, Ming Wang, Yuanxue Huang, Lisa Worrillow,[...]. J Pathol Clin Res 2015
39
22

Primary breast lymphoma.
Chan Y Cheah, Belinda A Campbell, John F Seymour. Cancer Treat Rev 2014
65
22

Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
Juan Wang, Yamei Wang, Fangrong Shen, Yanting Xu, Yinghui Zhang, Xinwei Zou, Jinhua Zhou, Youguo Chen. Cancer Med 2018
14
11

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
11

A framework for oligonucleotide microarray preprocessing.
Benilton S Carvalho, Rafael A Irizarry. Bioinformatics 2010
940
11

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.
Suyoun Chung, Hanae Suzuki, Takashi Miyamoto, Naofumi Takamatsu, Ayako Tatsuguchi, Koji Ueda, Kyoko Kijima, Yusuke Nakamura, Yo Matsuo. Oncotarget 2012
108
11

Current and emerging treatment options for mantle cell lymphoma.
Bita Fakhri, Brad Kahl. Ther Adv Hematol 2017
16
11

The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor.
Yong-Soon Cho, Yingjin Kang, Kuglae Kim, Young-Je Cha, Hyun-Soo Cho. Biochem Biophys Res Commun 2014
19
11

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia.
Houda Alachkar, Martin B G Mutonga, Klaus H Metzeler, Noreen Fulton, Gregory Malnassy, Tobias Herold, Karsten Spiekermann, Stefan K Bohlander, Wolfgang Hiddemann, Yo Matsuo,[...]. Oncotarget 2014
52
11

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
Lijs Beke, Cenk Kig, Joannes T M Linders, Shannah Boens, An Boeckx, Erika van Heerde, Marc Parade, An De Bondt, Ilse Van den Wyngaert, Tarig Bashir,[...]. Biosci Rep 2015
48
11

Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells.
Sandra Van Lint, Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Du Four, Kevin Van der Jeught, Lukasz Bialkowski,[...]. Cancer Immunol Res 2016
66
11

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis.
Karen Dybkær, Martin Bøgsted, Steffen Falgreen, Julie S Bødker, Malene K Kjeldsen, Alexander Schmitz, Anders E Bilgrau, Zijun Y Xu-Monette, Ling Li, Kim S Bergkvist,[...]. J Clin Oncol 2015
74
11

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
Mark R Pickard, Andrew R Green, Ian O Ellis, Carlos Caldas, Vanessa L Hedge, Mirna Mourtada-Maarabouni, Gwyn T Williams. Breast Cancer Res 2009
110
11

Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.
Suely K N Marie, Oswaldo K Okamoto, Miyuki Uno, Ana Paula G Hasegawa, Sueli M Oba-Shinjo, Tzeela Cohen, Anamaria A Camargo, Ana Kosoy, Carlos G Carlotti, Silvia Toledo,[...]. Int J Cancer 2008
110
11

MELK-a conserved kinase: functions, signaling, cancer, and controversy.
Ranjit Ganguly, Ahmed Mohyeldin, Jordyn Thiel, Harley I Kornblum, Monique Beullens, Ichiro Nakano. Clin Transl Med 2015
70
11


IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms.
Elke De Bruyne, Tomas J Bos, Frans Schuit, Els Van Valckenborgh, Eline Menu, Lieven Thorrez, Peter Atadja, Helena Jernberg-Wiklund, Karin Vanderkerken. Blood 2010
64
11

Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth.
Ramakrishna Edupuganti, Juliana M Taliaferro, Qiantao Wang, Xuemei Xie, Eun Jeong Cho, Fnu Vidhu, Pengyu Ren, Eric V Anslyn, Chandra Bartholomeusz, Kevin N Dalby. Bioorg Med Chem 2017
19
11

Identification of potential therapeutic targets in prostate cancer through a cross-species approach.
Sarah Jurmeister, Antonio Ramos-Montoya, Chiranjeevi Sandi, Nelma Pértega-Gomes, Karan Wadhwa, Alastair D Lamb, Mark J Dunning, Jan Attig, Jason S Carroll, Lee Gd Fryer,[...]. EMBO Mol Med 2018
21
11

Treatment of Diffuse Large B-Cell Lymphoma.
Kana Miyazaki. J Clin Exp Hematop 2016
43
11

MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
Lili Ren, Boya Deng, Vassiliki Saloura, Jae-Hyun Park, Yusuke Nakamura. Oncol Rep 2019
9
11

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells.
Taigo Kato, Hiroyuki Inoue, Seiya Imoto, Yoshinori Tamada, Takashi Miyamoto, Yo Matsuo, Yusuke Nakamura, Jae-Hyun Park. Oncotarget 2016
38
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.